Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of Immune Globulin Intravenous (Human) IGIV-SN in Pediatric Subjects With Primary Humoral Immunodeficiency

NCT03492710 is registered in ClinicalTrials.gov with Green Cross Corporation as lead sponsor.

NCT NCT03492710
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03492710 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of Immune Globulin Intravenous (Human) IGIV-SN in Pediatric Subjects With Primary Humoral Immunodeficiency
Lead sponsor
Green Cross Corporation
Phase
Phase 3
Overall status
Withdrawn
Start date
April 30, 2019
Completion date
April 30, 2019
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

primary immune deficiency disorder